摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

epi-1-O-Allyl-2,3,4,5-tetra-O-benzyl-D-chiro-inositol | 135355-09-8

中文名称
——
中文别名
——
英文名称
epi-1-O-Allyl-2,3,4,5-tetra-O-benzyl-D-chiro-inositol
英文别名
(1R,2S,3R,4R,5S,6S)-2,3,4,5-tetrakis(phenylmethoxy)-6-prop-2-enoxycyclohexan-1-ol
epi-1-O-Allyl-2,3,4,5-tetra-O-benzyl-D-chiro-inositol化学式
CAS
135355-09-8
化学式
C37H40O6
mdl
——
分子量
580.721
InChiKey
USTYCLMGJFBSMX-FCDJPCGASA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    5.6
  • 重原子数:
    43
  • 可旋转键数:
    15
  • 环数:
    5.0
  • sp3杂化的碳原子比例:
    0.3
  • 拓扑面积:
    66.4
  • 氢给体数:
    1
  • 氢受体数:
    6

反应信息

点击查看最新优质反应信息

文献信息

  • Syntheses of Penta-<b><i>O</i></b>-benzyl-<b><i>myo</i></b>-inositols,<b><i>O</i></b>-<b><i>β</i></b>-<b>L</b>-Arabinosyl-(1 → 2)-<b><i>sn</i></b>-<b><i>myo</i></b>-inositol,<b><i>O</i></b>-<b><i>α</i></b>-<b>D</b>-Galactosyl-(1 → 3)-<b><i>sn</i></b>-<b><i>myo</i></b>-inositol, and<b><i>O</i></b>-<b><i>α</i></b>-<b>D</b>-Galactosyl-(1 → 6)-<b><i>O</i></b>-<b><i>α</i></b>-<b>D</b>-galactosyl-(1 → 3)-<b><i>sn</i></b>-<b><i>myo</i></b>-inositol
    作者:Shinkiti Koto、Motoko Hirooka、Toyosaku Yoshida、Kazuhiro Takenaka、Chizuru Asai、Toshiki Nagamitsu、Hiroaki Sakuma、Michiyo Sakurai、Shinichi Masuzawa、Mitsuo Komiya、Tadaaki Sato、Shonosuke Zen、Kazuo Yago、Fumiya Tomonaga
    DOI:10.1246/bcsj.73.2521
    日期:2000.11
    Two-step conversions of myo-inositol into (±)-2,3,4,5,6- and 1,3,4,5,6-penta-O-benzyl-myo-inositols are described. Starting from these monohydroxy derivatives of myo-inositol, O-β-L-arabinopyranosyl-(1 → 2)-sn-myo-inositol from Japanese green tea [SENCHA], Camellia sinensis, and O-α-D-galactopyranosyl-(1 → 3)-sn-myo-inositol (galactinol) as well as its homolog, O-α-D-galactopyranosyl-(1 → 6II)-galactinol, were synthesized by way of the in situ activating glycosylation procedure.
    本文描述了肌醇向(±)-2,3,4,5,6-和1,3,4,5,6-五-O-苄基-肌醇的两步转化过程。从这些单羟基衍生的肌醇出发,通过原位活化糖基化程序合成了来自日本绿茶(煎茶,山茶属)的O-β-L-阿拉伯呋喃糖基-(1→2)-sn-肌醇和O-α-D-半喃糖基-(1→3)-sn-肌醇(半乳糖醇)及其同系物,O-α-D-半喃糖基-(1→6II)-半乳糖醇
  • Relative reactivity of hydroxyl groups in inositol derivatives: role of metal ion chelation
    作者:Subramanian Devaraj、Rajendra C. Jagdhane、Mysore S. Shashidhar
    DOI:10.1016/j.carres.2009.04.007
    日期:2009.7
    one hydroxyl group via their alkali metal alkoxides (sodium or lithium) preferentially occurs at a hydroxyl group having a vicinal cis-oxygen atom. In general the observed selectivity is relatively higher for lithium alkoxides than for the corresponding sodium alkoxide. The observed regioselectivity is also dependent on other factors such as the solvent and reaction temperature. A perusal of the results
    含有一个以上羟基的肌醇衍生物经由其碱属醇盐()的O-烷基化优先发生在具有邻位顺式氧原子的羟基上。通常,观察到的对于烷氧基的选择性比对相应的烷氧基的选择性更高。观察到的区域选择性还取决于其他因素,例如溶剂和反应温度。对本文提供的结果以及文献中提供的结果的仔细研究表明,肌醇衍生物属离子的螯合在观察到的区域选择性中起着重要作用。与反应的羟基的轴向或赤道位置有关的立体因素对这些O-烷基化反应的结果没有太大贡献。
  • An Effective Strategy for the Synthesis of 6-O-(2-Amino-2-deoxy-.alpha.-D-glucopyranosyl)-D-chiro- and -D-myo-inositol 1-Phosphate Related to Putative Insulin Mimetics
    作者:Carlos Jaramillo、Jose-Luis Chiara、Manuel Martin-Lomas
    DOI:10.1021/jo00090a035
    日期:1994.6
    Two glycosylinositol phosphates related to putative insulin mimetics, 6-O-(2-amino-2-deoxy-alpha-D-glucopyranosyl)-D-chiro-inositol 1-phosphate (1) and 6-O-(2-amino-2-deoxy-alpha-D-glucopyranosyl)-D-myo-inositol 1-phosphate (2), have been synthesized from selectively protected and enantiomerically pure D-chiro- and myo-inositol derivatives. The D-chiro-inositol unit was prepared in a multigram scale from D-glucose using the Ferrier's carbocyclization route, and it was transformed into the corresponding myo epimer by an oxidation-reduction sequence. The trichloroacetimidate method was applied efficiently for the key glycosylation of the inositol derivatives.
查看更多

同类化合物

(βS)-β-氨基-4-(4-羟基苯氧基)-3,5-二碘苯甲丙醇 (S,S)-邻甲苯基-DIPAMP (S)-(-)-7'-〔4(S)-(苄基)恶唑-2-基]-7-二(3,5-二-叔丁基苯基)膦基-2,2',3,3'-四氢-1,1-螺二氢茚 (S)-盐酸沙丁胺醇 (S)-3-(叔丁基)-4-(2,6-二甲氧基苯基)-2,3-二氢苯并[d][1,3]氧磷杂环戊二烯 (S)-2,2'-双[双(3,5-三氟甲基苯基)膦基]-4,4',6,6'-四甲氧基联苯 (S)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (R)富马酸托特罗定 (R)-(-)-盐酸尼古地平 (R)-(-)-4,12-双(二苯基膦基)[2.2]对环芳烷(1,5环辛二烯)铑(I)四氟硼酸盐 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[((6-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[(4-叔丁基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[(3-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-4,7-双(3,5-二-叔丁基苯基)膦基-7“-[(吡啶-2-基甲基)氨基]-2,2”,3,3'-四氢1,1'-螺二茚满 (R)-3-(叔丁基)-4-(2,6-二苯氧基苯基)-2,3-二氢苯并[d][1,3]氧杂磷杂环戊烯 (R)-2-[((二苯基膦基)甲基]吡咯烷 (R)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (N-(4-甲氧基苯基)-N-甲基-3-(1-哌啶基)丙-2-烯酰胺) (5-溴-2-羟基苯基)-4-氯苯甲酮 (5-溴-2-氯苯基)(4-羟基苯基)甲酮 (5-氧代-3-苯基-2,5-二氢-1,2,3,4-oxatriazol-3-鎓) (4S,5R)-4-甲基-5-苯基-1,2,3-氧代噻唑烷-2,2-二氧化物-3-羧酸叔丁酯 (4S,4''S)-2,2''-亚环戊基双[4,5-二氢-4-(苯甲基)恶唑] (4-溴苯基)-[2-氟-4-[6-[甲基(丙-2-烯基)氨基]己氧基]苯基]甲酮 (4-丁氧基苯甲基)三苯基溴化磷 (3aR,8aR)-(-)-4,4,8,8-四(3,5-二甲基苯基)四氢-2,2-二甲基-6-苯基-1,3-二氧戊环[4,5-e]二恶唑磷 (3aR,6aS)-5-氧代六氢环戊基[c]吡咯-2(1H)-羧酸酯 (2Z)-3-[[(4-氯苯基)氨基]-2-氰基丙烯酸乙酯 (2S,3S,5S)-5-(叔丁氧基甲酰氨基)-2-(N-5-噻唑基-甲氧羰基)氨基-1,6-二苯基-3-羟基己烷 (2S,2''S,3S,3''S)-3,3''-二叔丁基-4,4''-双(2,6-二甲氧基苯基)-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2S)-(-)-2-{[[[[3,5-双(氟代甲基)苯基]氨基]硫代甲基]氨基}-N-(二苯基甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[((1S,2S)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[[((1R,2R)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2-硝基苯基)磷酸三酰胺 (2,6-二氯苯基)乙酰氯 (2,3-二甲氧基-5-甲基苯基)硼酸 (1S,2S,3S,5S)-5-叠氮基-3-(苯基甲氧基)-2-[(苯基甲氧基)甲基]环戊醇 (1S,2S,3R,5R)-2-(苄氧基)甲基-6-氧杂双环[3.1.0]己-3-醇 (1-(4-氟苯基)环丙基)甲胺盐酸盐 (1-(3-溴苯基)环丁基)甲胺盐酸盐 (1-(2-氯苯基)环丁基)甲胺盐酸盐 (1-(2-氟苯基)环丙基)甲胺盐酸盐 (1-(2,6-二氟苯基)环丙基)甲胺盐酸盐 (-)-去甲基西布曲明 龙蒿油 龙胆酸钠 龙胆酸叔丁酯 龙胆酸 龙胆紫-d6 龙胆紫